EVERSANA™ Adds Seeker Health® to Growing Life Science Services Platform

News provided by

Oct 03, 2018, 10:01 ET

CHICAGO, Oct. 3, 2018 /PRNewswire/ -- EVERSANA,™ the leading independent provider of global services to the life science industry, today announced the addition of Seeker Health® to its platform. Headquartered in Palo Alto, Calif., Seeker Health offers breakthrough digital patient identification technology to accelerate drug development and commercialization for biopharmaceutical companies. The company excels at identifying and engaging patients with complex diseases for clinical trials and patient databases. Now powered by EVERSANA, Seeker Health technology will be applied throughout the full product lifecycle, helping clients create stronger patient relationships through continued engagement.

"We face a pivotal shift in healthcare as medicines become increasingly more precise, serving smaller and harder-to-find patient populations. Our technology has already helped biopharmaceutical companies accelerate clinical trial enrollment, launch therapies faster and reach the patients who need them. Now, we can have an even greater impact by engaging patients throughout the entire lifecycle of a medicine," shared Sandra Shpilberg, founder & president, Seeker Health. "It's been an honor to see our idea grow into technology that has such a profound impact on patients and drug development."

Seeker Health complements EVERSANA's suite of patient-focused capabilities, which include service and support HUB models, specialty pharmacy distribution, and The Patient Experience Project, a full-service, patient-centric communications firm serving the healthcare industry. The Seeker Portal^TM, a proprietary patient-lead management system that is pending patent, and PEPTrials, a patient-centered model for clinical trial recruitment and enrollment, will immediately work together to advance recruitment for current trials and assist clients in developing more patient-focused clinical research programs.

"As people use technology in their daily lives, our industry has a tremendous opportunity to leverage technology to treat rare disease," added Jim Lang, chief executive officer, EVERSANA. "From patient databases and research panels to ongoing therapy adherence, EVERSANA is well-positioned to help our clients create value for all stakeholders, and most importantly, for their patients."

Seeker Health will continue to operate from Palo Alto with Shpilberg leading the team and operations. EVERSANA, which unveiled its brand earlier this week, encompasses seven premier service providers including Dohmen Life Science Services, The Access Group, Alliance Life Sciences, Health Strategies Group, Triplefin, Patient Experience Project, and Seeker Health. Together as EVERSANA, the organization delivers a fully-integrated service portfolio to help life science leaders create value for key constituents across the product lifecycle.

About EVERSANA™

EVERSANA is the leading independent provider of global services to the life science industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies to advance life science services for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.

SOURCE EVERSANA